Skip to content

Effects of Osteopathic Treatment on Pulmonary Function After Coronary Artery Bypass Graft Surgery

Effect of Osteopathy on Pulmonary Function in Patients After Coronary Artery Bypass Graft Surgery: a Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01714791
Acronym
OSTinCARE
Enrollment
112
Registered
2012-10-26
Start date
2010-01-31
Completion date
2017-12-31
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Complication of Coronary Artery Bypass Graft, Respiratory Depression, Pain, Quality of Life

Keywords

Coronary Artery Bypass Graft, Osteopathic Medicine, Vital Capacity, Quality of Life, Cardiac rehabilitation

Brief summary

The purpose of this study is to determine the short and long term effects of osteopathic treatment on pulmonary function, pain and quality of life in patients after coronary artery bypass graft (CABG) surgery. The study is a randomized controlled trial.

Detailed description

Coronary artery bypass graft (CABG) surgery is performed worldwide. Several studies have found that there is a decrease in pulmonary function, loss of thoracic mobility and a high prevalence of chronic poststernotomy pain (CPSP) after CABG. So far there is no effective treatment for these conditions. The OstinCare study aims to investigate whether osteopathic treatment has an added value in the treatment of these patients.

Interventions

OTHERUsual care

Patients exercise at a heart rate corresponding to 65% of baseline Vo2peak. Each exercise training session takes 40-60 minutes. Exercise time is apportioned as follows: 42% on the treadmill, 33% on the circle ergometer and 25% on the arm cranking device. All patients exercise under close supervision 3 days per week for a total duration of 12 weeks.

Patients receive 4 osteopathic treatments (OT). OT is performed in week 4, 5, 8 and 12 postoperative. Depending on what is found in the patient, treatments consist mostly of one or more of the following approaches: * Structural High Velocity Low Amplitude-techniques. * Muscle Energy Techniques. * General osteopathic mobilisations. * Functional techniques (Sutherland-, Jones-techniques,…) including inhibition techniques. * Fascia techniques. * Soft tissue- and connective tissue techniques. * Neurovisceral and neurolymphatic reflex techniques. * Fluidal techniques (lymphatic manipulative techniques,...). * Visceral manipulations. * Neurocranial and viscerocranial techniques.

Sponsors

Hartcentrum Hasselt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Planned Coronary Artery Bypass Graft (CABG) surgery at the Jessa Hospital Hasselt * Planned Endoscopic Atraumatic Coronary Artery Bypass (endo ACAB) surgery at the Jessa Hospital * Planned Minimal Invasive Aortic Valve Replacement (mini AVR) surgery at the Jessa Hospital

Exclusion criteria

* Thoracic surgery in the past * Redo CABG * Complications after CABG, requiring long-term (more than 6 days) admission to intensive care * Pathologies of the lungs * Pathologies of the heart, other than the coronary artery disease * Surgery in the sub diaphragmatic region: epigastric region, left and right hypochondriac region.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in slow vital capacity (SVC) at 12 weeks.preoperative (baseline) and 12 weeks postoperativeA Slow Vital Capacity (SVC) test will be performed at each time point.

Secondary

MeasureTime frameDescription
Change from baseline in slow vital capacity (SVC) at 52 weeks.preoperative (baseline) and 52 weeks postoperativeA SVC test will be performed at each time point.
Change from baseline in McNew quality of life questionnaire at 12 weeks.3 weeks postoperative (baseline) and 12 weeks postoperativeMcNew questionnaire will be done at 3 and 12 weeks after surgery.
Change from baseline in McNew quality of life questionnaire at 52 weeks.3 weeks postoperative (baseline) and 52 weeks postoperativeMcNew questionnaire will be done at 3, 12 and 52 weeks after surgery.
Change in pain from baseline on Visual Analogue Scale (VAS) at 12 weeks postoperative.3 weeks postoperative (baseline) and 12 weeks postoperativePain will be evaluated at 3 and 12 weeks after surgery.
Change in thoracic stiffness from baseline on VAS at 12 weeks postoperative.3 weeks postoperative (baseline) and 12 weeks postoperativeThoracic stiffness will be evaluated at 3, 12 weeks after surgery.
Change in thoracic stiffness from baseline on VAS at 52 weeks postoperative.3 weeks postoperative (baseline) and 52 weeks postoperativeThoracic stiffness will be evaluated at 3, 12 and 52 weeks after surgery.
Change in pain from baseline on VAS at 52 weeks postoperative.3 weeks postoperative (baseline) and 52 weeks postoperativePain will be evaluated at 3, 12 and 52 weeks after surgery.

Other

MeasureTime frameDescription
Change from baseline in maximal aerobic capacity (VO2max) at 12 weeks postoperative3 weeks postoperative (baseline) and 12 weeks postoperativeAll patients will perform a maximal cardiopulmonary exercise test on a cycle ergometer. The test will be performed at the cardiac rehabilitation centre by a trained operator and under supervision of a cardiologist.
Changes in thoracic mobility at 4, 12 and 52 weeks postoperative.4, 12 and 52 weeks postoperativeOsteopathic clinical examination of the thorax.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026